On Dec. 21, 2022, the U.S. Department of Health and Human Services (HHS), through the Administration for Strategic Preparedness and Response (ASPR), announced announced that that were making additional supply of Tamiflu available to jurisdictions to respond to an increased demand for the antiviral during this flu season, including through the Strategic National Stockpile (SNS).

HHS partnered closely with jurisdictions for months to address any strain to health care systems created by the confluence of COVID-19, flu, and RSV ﾖ including a specific focus on expanding access to medicines under high demand.